Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion

Nurofen

  • Haleon takes hit from ‘weak cold and flu season’ but Sensodyne shines

    Retail

    After being spun out from GSK in the biggest London IPO in decades, City analyst are looking for more from the emblematic FTSE 100 consumer healthcare powerhouse with roots in a Lombard Street apothecary shop Fewer sniffles during the winter have sent a chill through sales volumes at Haleon, the FTSE 100 over-the-counter remedy maker. [...]

    Haleon has reported its 2024 results
  • Dettol and Nurofen owner Reckitt to sell divisions as it slims down

    Retail

    Dettol, Lysol, Durex, and Nurofen owner Reckitt has delivered a mixed financial performance for 2024, with modest like-for-like revenue growth and increased profitability but a decline in reported net revenue due to foreign exchange impacts. Like-for-like net revenue rose 1.4 per cent, driven by gains in Hygiene and Health, while Nutrition declined. Hygiene and Health [...]

    Reckitt, the owner of brands such as Dettol, has struggled with growth headwinds over the past two years

Trending Articles

  • Revealed: Secret Treasury plan to tax State Pension before it is paid out

  • Burnham’s new chief of staff ran City firm advising Thames Water and rival Heathrow bidder

  • Two solicitors linked to Post Office scandal charged with misconduct

  • Barclays and Lloyds join banking sector plan for digital ID

  • Reeves’ new tax charge on cash ISAs faces fierce industry backlash

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM. All rights reserved.
About · Contact · Terms · Privacy